Reproducibility of [11C]FLB 457 binding in extrastriatal regions

被引:60
作者
Sudo, Y [1 ]
Suhara, T [1 ]
Inoue, M [1 ]
Ito, H [1 ]
Suzuki, K [1 ]
Saijo, T [1 ]
Halldin, C [1 ]
Farde, L [1 ]
机构
[1] Natl Inst Radiol Sci, Div Adv Technol Med Imaging, Inage Ku, Chiba 2638555, Japan
关键词
positron emission tomography (PET); dopamine receptors; reproducibility; parametric image;
D O I
10.1097/00006231-200111000-00008
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Extrastriatal D-2 dopamine receptors represent an important target of research into the pathophysiology and pharmacotherapy of psychiatric disorders. The high affinity radioligand [C-11]FLB 457 makes possible the measurement of low concentrations of D-2 receptors in extrastriatal regions using positron emission tomography (PET). The aim of this study was to assess the test/retest variability and reliability of [C-11]FLB 457 binding using a reference tissue model. Eight healthy male subjects (aged 20-33 years) underwent two [C-11]FLB 457 PET examinations. Radioactivity in the cerebellum was used as the reference. The binding potentials (BPs) for five cortical regions of interest (ROIs) were calculated using the reference tissue model. The BP was also calculated for each pixel in the form of parametric images. Reproducibility was assessed both for the ROI method and for the parametric images. The test/retest reproducibility for [C-11]FLB 457 binding was good, with a mean variability ranging from 4.5% for the thalamus to 15.5% for the hippocampus. The parametric images also demonstrated good reproducibility. These results support the suitability of using [C-11]FLB 457 for the quantitative evaluation of extrastriatal D-2 receptors and for protocols requiring repeated measurements in the same individual. ((C) 2001 Lippincott Williams & Wilkins).
引用
收藏
页码:1215 / 1221
页数:7
相关论文
共 26 条
[1]  
Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO
[2]  
2-G
[3]   Incorporating prior knowledge into image registration [J].
Ashburner, J ;
Neelin, P ;
Collins, DL ;
Evans, A ;
Friston, K .
NEUROIMAGE, 1997, 6 (04) :344-352
[4]  
Brix G, 1997, J NUCL MED, V38, P1614
[5]   A PET study of [C-11]FLB 457 binding to extrastriatal D-2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients [J].
Farde, L ;
Suhara, T ;
Nyberg, S ;
Karlsson, P ;
Nakashima, Y ;
Hietala, J ;
Halldin, C .
PSYCHOPHARMACOLOGY, 1997, 133 (04) :396-404
[6]   QUANTITATIVE-ANALYSIS OF D2 DOPAMINE RECEPTOR-BINDING IN THE LIVING HUMAN-BRAIN BY PET [J].
FARDE, L ;
HALL, H ;
EHRIN, E ;
SEDVALL, G .
SCIENCE, 1986, 231 (4735) :258-261
[7]  
Fleiss J., 1986, Reliability of measurement: the design and analysis of clinical experiments
[8]   Parametric imaging of ligand-receptor binding in PET using a simplified reference region model [J].
Gunn, RN ;
Lammertsma, AA ;
Hume, SP ;
Cunningham, VJ .
NEUROIMAGE, 1997, 6 (04) :279-287
[9]   Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET [J].
Gunn, RN ;
Sargent, PA ;
Bench, CJ ;
Rabiner, EA ;
Osman, S ;
Pike, VW ;
Hume, SP ;
Grasby, PM ;
Lammertsma, AA .
NEUROIMAGE, 1998, 8 (04) :426-440
[10]  
Hall H, 1996, SYNAPSE, V23, P115, DOI 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO